Governance
Ownership, Funding and Editorial Separation
Who publishes this platform, who owns it, how it is funded, and what separates the commercial side from the records.
This page identifies the publisher, its ownership, and its funding, and sets out the structural separation between any commercial activity and the entity monitoring records. A platform that publishes regulatory records about named businesses owes the same transparency it asks for, and any field not yet supplied renders as pending rather than being omitted.
Key findings
- No provider or pharmacy holds any ownership interest in this publication.
- No affiliate, referral, sponsorship, or financial relationship exists with any provider or pharmacy.
- Entity records are generated by a fixed rule from primary sources, with no record-level discretion.
- The status vocabulary is fixed and published; the build rejects any term outside it.
- Fields not yet supplied render as pending rather than being quietly omitted.
| Publisher | CompoundedRxMonitor |
|---|---|
| Registered legal entity | Verification Pending publisher must supply before launch |
| Jurisdiction | Verification Pending publisher must supply before launch |
| Accountable editor | Verification Pending publisher must supply before launch |
| Beneficial owner | Verification Pending publisher must supply before launch |
| Provider ownership interest | None |
| Pharmacy ownership interest | None |
| Commercial relationships | None. No affiliate, referral, sponsorship, ownership, or financial relationship with any p |
| Funding source | Verification Pending publisher must supply before launch |
What separates commercial activity from the records
| Layer | How it works | Why discretion cannot enter |
|---|---|---|
| Entity records | Generated by a fixed rule from primary sources | No editorial discretion at the record level |
| Status vocabulary | Fixed and published; the build rejects any term outside it | Cannot drift by editorial choice |
| Pricing figures | Dated captures, recomputed as totals | Arithmetic is published and rerunnable |
| Rankings | Sorted on a single published field | No weighting, no composite score, no discretion |
| Corrections | Made against primary sources only | Not against assertions, in either direction |
Why does this matter more here than on a normal publication?
This platform names real, identifiable businesses and publishes regulatory records about them — federal registration status, FDA inspection dates, Form 483 issuance, warning letters. Those records affect commercial reputation.
A publication doing that while concealing its own ownership invites the obvious question: who benefits from these records reading as they do? The answer has to be checkable, not asserted.
So the separation is structural rather than editorial. Entity records are generated by a fixed rule from primary sources. There is no scoring function in the codebase, no weighting, and no field an editor can adjust to favour or disfavour an entity.
What this means
- No provider or pharmacy holds any ownership interest or pays for anything.
- Entity records are rule-generated, with the rule published.
- Outstanding governance fields are named rather than omitted.
What this does not mean
- That this platform is complete on governance — several fields are outstanding.
- That rule-generation removes all judgement — source selection is still editorial.
- That absence of a commercial relationship guarantees accuracy.
- An NPI confirms a provider identifier exists in the CMS registry. It does not by itself confirm an active licence, licensing state, board certification, specialty, or disciplinary history.
- State licence verification for each reviewer is a separate check against the relevant state board and is not established here.
- Publisher identity fields are outstanding and must be supplied before launch.
- This page describes structure, not an external audit. No third-party governance audit has been performed.
Related records in this section
Section hub: Governance · Methodology · Status definitions · Right to respond
Frequently asked questions
Who owns this platform?
Beneficial ownership is not yet published and renders as pending. No provider or pharmacy holds any ownership interest.
How is it funded?
Not by providers, pharmacies, advertising, or sponsored content. The actual funding source is outstanding and must be published before launch.
Can a pharmacy influence its own record?
Only by supplying a primary source through the right-to-respond route. Records are rule-generated and there is no field an editor can adjust.
Does any provider pay for coverage?
No. No affiliate, referral, sponsorship, or financial relationship exists with any provider.
Sources
Update history
| Date | Change |
|---|---|
| 2026-07-23 | Record published at current snapshot. |
Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.